JP2007063236A - Composition for improving quality of sleep - Google Patents

Composition for improving quality of sleep Download PDF

Info

Publication number
JP2007063236A
JP2007063236A JP2005255104A JP2005255104A JP2007063236A JP 2007063236 A JP2007063236 A JP 2007063236A JP 2005255104 A JP2005255104 A JP 2005255104A JP 2005255104 A JP2005255104 A JP 2005255104A JP 2007063236 A JP2007063236 A JP 2007063236A
Authority
JP
Japan
Prior art keywords
sleep
composition
aminobutyric acid
quality
improving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005255104A
Other languages
Japanese (ja)
Inventor
Yoshihiro Yoshida
善廣 吉田
Kenji Horie
健二 堀江
Takayuki Ishiwatari
貴之 石渡
Shiyouko Yoshikawa
肖子 吉川
Junichiro Arai
淳一郎 新井
Busaku Kin
武祚 金
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharma Foods International Co Ltd
Original Assignee
Pharma Foods International Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Foods International Co Ltd filed Critical Pharma Foods International Co Ltd
Priority to JP2005255104A priority Critical patent/JP2007063236A/en
Publication of JP2007063236A publication Critical patent/JP2007063236A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a composition for improving the quality of sleep wherein food materials are employed to obtain good taste in no anxiety of excessive ingestion and the quality of sleep can be improved by ingestion of the composition at the bed time. <P>SOLUTION: The composition for improving the quality of sleep includes γ-aminobutyric acid. In other words, the composition for improving the quality of sleep includes γ-aminobutyric acid, as an active ingredient, that has the action to promote the deep sleep by lowering the deep bodily temperature with the intake at bed time. Further, the sleep quality improving composition can be used in food and beverage. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

本発明は、就寝前に経口で摂取することにより睡眠の質を改善させることができる、より詳しくは就寝後の深部体温の低下を促すことのできる、睡眠の質改善用組成物に関する。 The present invention relates to a composition for improving sleep quality, which can improve the quality of sleep by ingesting orally before going to bed, and more specifically, can promote a decrease in deep body temperature after going to bed.

現代の生活において、運動不足、ストレス及び環境汚染などで上質な睡眠が取れないことにより仕事の効率、精神力及び病気に対する抵抗力の低下が問題のひとつとして注目されている。また、上質な睡眠は美容にとっても重要である。睡眠障害など症状が見られる場合は睡眠薬などの医薬品が処方されるが、依存症などの副作用が見られる場合もあるため、それほど深刻な不眠でない場合は、もう少し手軽な方法が求められる。従って、効果が確実で、副作用がなく、簡単に実行できる睡眠の質改善方法として、睡眠の効果を高める飲食品用の組成物がいくつか提案されてきた。 In modern life, one of the problems has been a decline in work efficiency, mental power, and resistance to illness due to lack of exercise, stress and environmental pollution, and so on. High quality sleep is also important for beauty. Drugs such as sleeping pills are prescribed when symptoms such as sleep disorders are observed, but side effects such as addiction may be seen, so if it is not so serious insomnia, a slightly easier method is required. Therefore, several compositions for foods and drinks that enhance the effect of sleep have been proposed as methods for improving sleep quality that are surely effective, have no side effects, and can be easily executed.

例えば、特許文献1では、バレリアーナ属植物又はその抽出物、鎮静作用を有する植物又はその抽出物及びγ−アミノ酪酸を含んだ睡眠障害に有効な組成物が提案されている。また、特許文献2では、テアニンを含有することを特徴とする睡眠促進用組成物が提案されている。 For example, Patent Document 1 proposes a composition effective for sleep disorders containing a genus Valeriana or an extract thereof, a plant having a sedative action or an extract thereof, and γ-aminobutyric acid. Moreover, in patent document 2, the composition for sleep promotion characterized by containing theanine is proposed.

一方、近年、睡眠の質の向上における目安として、深部体温が注目されている。(非特許文献1を参照。)即ち、日中の運動などにより深部体温を挙げておき、就寝後の深部体温との落差が大きい方がより深く快適な睡眠が得られる、という考え方である。 On the other hand, in recent years, deep body temperature has attracted attention as a measure for improving sleep quality. (See Non-Patent Document 1.) That is, the idea is that the deep body temperature is raised by daytime exercise, etc., and the deeper and more comfortable sleep is obtained when the difference from the deep body temperature after going to bed is larger.

上記の特許文献記載の組成物や、これまでの睡眠改善用組成物では、この深部体温で具体的に評価したものは見られなかった。
特開2003−183174号公報 国際公開WO01/074352号公報 小田史郎ほか 北海道体育学研究, 36, p73. (2001)
None of the compositions described in the above-mentioned patent documents and the compositions for improving sleep so far were specifically evaluated at this deep body temperature.
JP 2003-183174 A International Publication WO01 / 074352 Shiro Oda et al. Hokkaido Physical Education Research, 36, p73. (2001)

本発明では、食品素材を用いて、味もよく、過剰摂取の心配もなく、就寝前に経口で摂取することにより睡眠の質を改善させることができる、特に入眠時の深部体温を下げることにより、深い睡眠を促すような睡眠の質改善用組成物を提供することを課題とする。 In the present invention, by using food materials, taste is good, there is no worry of overdose, and can be improved by taking orally before going to bed, especially by lowering the deep body temperature during sleep Another object of the present invention is to provide a composition for improving sleep quality that promotes deep sleep.

本発明者らは、上記課題を達成するために鋭意検討した結果、γ−アミノ酪酸を経口的に摂取することにより、入眠時の深部体温を下げ、ポリグラフ解析による睡眠深度を深めることを見出し、本発明を完成させるに至った。 As a result of intensive studies to achieve the above-mentioned problems, the present inventors have found that by taking γ-aminobutyric acid orally, the deep body temperature at the time of falling asleep is lowered, and the depth of sleep by polygraph analysis is increased, The present invention has been completed.

即ち、本発明の睡眠の質改善用組成物は、γ―アミノ酪酸を有効成分として含有することを特徴とする。 That is, the sleep quality improving composition of the present invention is characterized by containing γ-aminobutyric acid as an active ingredient.

上記睡眠の質改善用組成物においては、就寝後の深部体温の低下を促すことが好ましい。 In the sleep quality improving composition, it is preferable to promote a decrease in deep body temperature after going to bed.

本発明により、食品素材を用いて、味もよく、過剰摂取の心配もなく、就寝前に経口で摂取することにより睡眠の質を改善させることができる、質改善用組成物を提供することができる。 According to the present invention, it is possible to provide a quality improving composition that can improve the quality of sleep by ingesting orally before going to bed without using the food material, having good taste and worrying about excessive intake. it can.

発明のもう1つは、上記睡眠の質改善用組成物を含有することを特徴とする飲食品である。 Another aspect of the invention is a food or drink comprising the sleep quality improving composition.

本発明によれば、味もよく、過剰摂取の心配もなく、就寝前に飲食することにより睡眠の質を改善させることができる飲食品を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the food / beverage products which can improve the quality of sleep can be provided by eating and drinking before going to bed, without the worry of excessive intake and taste.

本発明の睡眠の質改善用組成物、又はこれを含有する飲食品によれば、就寝前の摂取で、深部体温を下げ、深めの眠りを促し、夜中に起きるのを防ぐなど睡眠の質を改善させることができるので、ひいては疲労回復や美容、健康の増進、日中の作業効率の改善などに役立てることも可能となる。 According to the composition for improving sleep quality of the present invention, or a food or drink containing the sleep quality, the sleep quality is improved by lowering the deep body temperature, promoting deep sleep, preventing waking up at night, etc. Since it can be improved, it can also be used to recover from fatigue, improve beauty, improve health, and improve daytime work efficiency.

本発明におけるγ−アミノ酪酸とは、一般にGABA(ギャバ)とも呼ばれ、自然界に広く分布している非タンパク質アミノ酸の1種を指す。食品の成分としても、茶、野菜類、穀類などに普通に含まれており、生体内においては、グルタミン酸が脱炭酸されて生成され、人体では特に、脳内の黒質、大脳基底核、視床下部等に高濃度に存在していることが分かっている。 In the present invention, γ-aminobutyric acid is generally called GABA and refers to one type of non-protein amino acid widely distributed in nature. As a food component, it is usually contained in tea, vegetables, cereals, etc., and in the living body, it is produced by decarboxylation of glutamic acid, and in the human body, especially in the substantia nigra, basal ganglia, thalamus It is known that it exists at a high concentration in the lower part.

本発明に用いられるγ−アミノ酪酸は、特に限定するものではないが、野菜、果物、穀物などから抽出されたγ−アミノ酪酸、発酵法により生産されたγ−アミノ酪酸、有機合成から生産されたγ−アミノ酪酸のことをいう。中でも、特に限定するものではないが、大量且つ安価にγ−アミノ酪酸を得ることができる乳酸菌による発酵法が好ましい。例えば、グルタミン酸ソ−ダ、ブドウ糖、パン酵母エキス等を含む培養液に、乳酸菌(ラクトバチルス
ブレ ビス(IFO12005株)、ラクトバチルス ヒルガルディーK−3株(FERM P−18422)等)の培養液を添加し、20〜 30℃で、1〜3日間培養し、この培養液を、加熱殺菌後、濾過して濾液を得る。なお、乳酸菌としてラクトバチルス
ヒルガルディー K−3株(FERM P−18422)を用いた場合、培養液中のγ−アミノ酪酸含量は約5質量%、固形分当りに換算するとγ−アミノ酪酸は約50%を占める。この濾液は、適宜濃縮してそのまま、又は更に乾燥して粉末として、本発明の睡眠の質改善用組成物に用いることができる。
The γ-aminobutyric acid used in the present invention is not particularly limited, but γ-aminobutyric acid extracted from vegetables, fruits, cereals, etc., γ-aminobutyric acid produced by fermentation, and produced from organic synthesis. It means γ-aminobutyric acid. Especially, although it does not specifically limit, the fermentation method by lactic acid bacteria which can obtain (gamma) -aminobutyric acid in large quantities and cheaply is preferable. For example, a culture solution of lactic acid bacteria (Lactobacillus brevis (IFO12005 strain), Lactobacillus hilgardi K-3 strain (FERM P-18422), etc.) is added to a culture solution containing glutamic acid soda, glucose, baker's yeast extract, etc. And it culture | cultivates at 20-30 degreeC for 1-3 days, and this culture solution is filtered after heat-sterilization, and a filtrate is obtained. In addition, when Lactobacillus hilgardy K-3 strain (FERM P-18422) is used as a lactic acid bacterium, the content of γ-aminobutyric acid in the culture broth is about 5% by mass. It accounts for about 50%. The filtrate can be appropriately concentrated and used as it is, or further dried and used as a powder in the composition for improving sleep quality of the present invention.

また、市販品「ファーマギャバ20―D」「ファーマギャバ100」(株式会社ファーマフーズ製)を用いてもよい。 Further, commercially available products “Pharmaca 20-D” and “Pharmaca 100” (manufactured by Pharma Foods Co., Ltd.) may be used.

本発明の組成物中または飲食品中のγ−アミノ酪酸の検出方法は特に限定されるものではないが、イオン交換カラムを用いての高速クロマトグラフィー(HPLC)で分離し、オルトフタルアルデヒド(OPA)によるポストカラムでの誘導体化後、蛍光検出器で検出定量する方法が好ましい。 Although the detection method of (gamma) -aminobutyric acid in the composition of this invention or food / beverage products is not specifically limited, It isolate | separates by the high performance chromatography (HPLC) using an ion exchange column, and orthophthalaldehyde (OPA). The method of detecting and quantifying with a fluorescence detector after derivatization with a post-column by) is preferred.

本発明の睡眠の質改善用組成物におけるγ−アミノ酪酸の含有量は、特に限定されるものではないが、γ−アミノ酪酸を5〜100質量%含むことが好ましい。含有量が5質量%未満であると、本睡眠の質改善用組成物を有効摂取量摂るのに大量の粉末や液体を摂取する必要が出てきたり、本睡眠の質改善用組成物を飲食品に添加する場合、高濃度で添加することになるため、好ましくない。 Although content of (gamma) -aminobutyric acid in the composition for sleep quality improvement of this invention is not specifically limited, It is preferable that 5-100 mass% of (gamma) -aminobutyric acid is included. If the content is less than 5% by mass, it may be necessary to ingest a large amount of powder or liquid in order to take an effective intake of the sleep quality improving composition, or the sleep quality improving composition may be consumed. When added to a product, it is not preferable because it is added at a high concentration.

本発明の睡眠の質改善用組成物の形態は特に制限はなく、用途に応じて溶液、粉末などを選択できる。粉末化の方法としては、熱風乾燥、噴霧乾燥、凍結乾燥、通常の公知の粉末化方法を採用できる There is no restriction | limiting in particular in the form of the composition for sleep quality improvement of this invention, A solution, powder, etc. can be selected according to a use. As a pulverization method, hot air drying, spray drying, freeze drying, or a general known pulverization method can be adopted.

本発明の睡眠の質改善用組成物は、上述した成分のほかに、賦形剤、乳化剤、安定剤、甘味料、pH調整剤、増粘剤、タンパク質、ペプチド、アミノ酸、脂質、多糖類、オリゴ糖等の通常食品に用いられる成分を含んでいてもよい。 In addition to the components described above, the composition for improving sleep quality of the present invention includes excipients, emulsifiers, stabilizers, sweeteners, pH adjusters, thickeners, proteins, peptides, amino acids, lipids, polysaccharides, Ingredients usually used in foods such as oligosaccharides may be included.

本発明の睡眠の質改善用組成物は、飲食品に加えるだけでなく投与形態に応じて種々の形に調製され、粉末(または顆粒)、ドリンク剤、錠剤、カプセル剤等として用いることもできる。 The composition for improving sleep quality of the present invention is not only added to foods and drinks, but also prepared in various forms according to the dosage form, and can also be used as powder (or granules), drinks, tablets, capsules and the like. .

本発明に包含される飲食品としては、乾燥食品、サプリメント等の固形食品、また、清涼飲料やスポーツドリンク・ミネラルウォーター、嗜好飲料等の液状飲食品を挙げることができる。固形食品としては特に限定されるものではないが、詳しくは、たとえば、練り製品、大豆加工品、ムース、ゼリー、ヨーグルト、冷菓、飴、チョコレート、ガム、クラッカー、ビスケット、クッキー、ケーキ、パン等が挙げられる。また、液状飲食品としては特に限定されるものではないが、詳しくは、たとえば、炭酸飲料、スポーツドリンク、清涼飲料、緑茶・ウーロン茶・紅茶・ハーブティー等の茶類、ココア飲料、濃縮果汁、濃縮還元ジュース、ストレートジュース、果実ミックスジュース、果肉入り果実ジュース、果汁入り飲料、果実・野菜ミックスジュース、野菜ジュース、ミネラルウォーター、牛乳、乳飲料等が挙げられる。 Examples of the foods and drinks included in the present invention include solid foods such as dried foods and supplements, and liquid foods and drinks such as soft drinks, sports drinks / mineral waters, and beverages. Although it is not particularly limited as a solid food, in detail, for example, kneaded products, processed soybean products, mousse, jelly, yogurt, frozen dessert, strawberry, chocolate, gum, crackers, biscuits, cookies, cakes, bread, etc. It is done. In addition, although it is not particularly limited as liquid food and drink, in detail, for example, carbonated drinks, sports drinks, soft drinks, teas such as green tea, oolong tea, black tea, herbal tea, cocoa drinks, concentrated fruit juice, concentrated Examples include reduced juice, straight juice, fruit mix juice, fruit juice containing fruit juice, beverage containing fruit juice, fruit / vegetable mix juice, vegetable juice, mineral water, milk, and milk drink.

本発明の飲食品の製法は特に限定されるものではなく、たとえば、γ−アミノ酪酸と他の原材料を粉体混合する製法、溶媒中にγ−アミノ酪酸と他の原材料を溶かし混合溶液とする製法、またその混合溶液を凍結乾燥する製法、噴霧乾燥する製法等、一般的な飲食品の製法を適用することができる。本発明の飲食品を製造する際に用いることができるγ−アミノ酪酸以外の成分は、γ−アミノ酪酸による所望の効果の発現が阻害されないかぎり、適宜所望の用途に合わせて選択することができる。   The production method of the food and drink of the present invention is not particularly limited. For example, a production method in which γ-aminobutyric acid and other raw materials are mixed with powder, or a mixed solution is prepared by dissolving γ-aminobutyric acid and other raw materials in a solvent. A general method for producing food and drink, such as a production method, a production method in which the mixed solution is freeze-dried, and a production method in which the solution is spray-dried, can be applied. Ingredients other than γ-aminobutyric acid that can be used in producing the food and drink of the present invention can be appropriately selected according to the desired use unless the expression of the desired effect by γ-aminobutyric acid is inhibited. .

本発明の飲食品における睡眠の質改善用組成物の添加量は、特に限定されるものではないが、0.1質量%以上100質量%以下が好ましい。0.1質量%未満であると、有効成分であるγ−アミノ酪酸の摂取が難しい。 The addition amount of the sleep quality improving composition in the food or drink of the present invention is not particularly limited, but is preferably 0.1% by mass or more and 100% by mass or less. If it is less than 0.1% by mass, it is difficult to take γ-aminobutyric acid as an active ingredient.

本発明である睡眠の質改善用組成物は、前記γ−アミノ酪酸を有効成分として含有するものである。その有効摂取量は年齢や性別、体質などにより異なるが、通常、就寝1回あたりγ−アミノ酪酸換算で50mgから500mgが好ましい。50mg以下では、あまり効果が体感できない。また、1回につきγ−アミノ酪酸換算で3,000mgほど摂取しても特に悪影響は見られないが、1回あたり500mg以上摂取しても、特に効果が顕著になるわけではない。 The composition for improving sleep quality according to the present invention contains the γ-aminobutyric acid as an active ingredient. The effective intake varies depending on the age, sex, constitution, etc., but is usually preferably 50 mg to 500 mg in terms of γ-aminobutyric acid per bedtime. If it is 50 mg or less, the effect cannot be experienced so much. In addition, even if it is ingested as much as 3,000 mg in terms of γ-aminobutyric acid at a time, no particular adverse effect is seen, but even if it is ingested at a dose of 500 mg or more, the effect is not particularly noticeable.

本発明の睡眠の質改善用組成物においては、上記有効摂取量投与して就寝後一時間以内に、深部体温を0.2℃以上低下させることが好ましい。深部体温低下が0.2℃以下であれば、睡眠の質改善効果が見られない。また、通常1.0℃以上深部体温が下がることは見られない。 In the composition for improving sleep quality of the present invention, it is preferable to lower the deep body temperature by 0.2 ° C. or more within one hour after going to bed after administration of the above effective intake. If the deep body temperature decrease is 0.2 ° C. or less, the sleep quality improvement effect is not seen. Moreover, it is not seen that deep body temperature falls normally 1.0 degreeC or more.

本発明において深部体温とは、体表近くの体温ではなく、体の内部の温度に近い体温を指す。実際の測定のしやすさからみて、直腸温が好ましい。 In the present invention, the deep body temperature refers to a body temperature close to the temperature inside the body, not the body temperature near the body surface. In view of ease of actual measurement, rectal temperature is preferable.

本発明において用いられるγ−アミノ酪酸の安全性は高く、たとえば、マウスを用いた急性毒性試験において5g/kg経口投与で死亡例はなく、一般状態および体重等に異常は認められない。食品衛生法上、その添加量に制限はない。しかも、従来の薬物と異なり、γ−アミノ酪酸による副作用は全く認められないので、本発明の組成物によれば、安全かつ効果的に睡眠の質を改善させることができる。 The safety of γ-aminobutyric acid used in the present invention is high. For example, in an acute toxicity test using mice, there is no death due to oral administration of 5 g / kg, and no abnormality is observed in the general state and body weight. Under the Food Sanitation Law, there is no limit to the amount added. In addition, unlike conventional drugs, no side effects due to γ-aminobutyric acid are observed. Therefore, according to the composition of the present invention, the quality of sleep can be improved safely and effectively.

以下実施例を挙げて本発明を具体的に説明するが、本発明はこれによって特に限定されるものではない。   EXAMPLES Hereinafter, the present invention will be specifically described with reference to examples, but the present invention is not particularly limited thereto.

(乳酸菌発酵γ−アミノ酪酸高含有素材の調製)
表1に示す割合で各成分を含有する発酵原料水溶液(pH5.0)50Lを、90℃で10分間加熱殺菌した後、同様の発酵原料液で前培養した乳酸菌(ラク
トバチルス ヒルガルディーK−3株(FERM P−18422))培養液50mLを接種し、30℃で3日間培養した。この発酵液を90℃で10分間加熱殺菌した後、濾過助剤を加えてろ過し、ろ液を得た。
(Preparation of lactic acid bacteria fermented γ-aminobutyric acid high content material)
Lactic acid bacteria (Lactobacillus hillgardi K-3 strain) pre-cultured with a similar fermentation raw material solution after 50 L of a fermentation raw material aqueous solution (pH 5.0) containing each component at the ratio shown in Table 1 was sterilized by heating at 90 ° C. for 10 minutes. (FERM P-18422)) 50 mL of the culture solution was inoculated and cultured at 30 ° C. for 3 days. This fermentation broth was sterilized by heating at 90 ° C. for 10 minutes, and then filtered with a filter aid to obtain a filtrate.

得られたろ液にデキストリン(三和澱粉株式会社製)を添加して、噴霧乾燥機にて乾燥、粉末化して乳酸菌発酵γ−アミノ酪酸高含有素材約11kgを得た。 Dextrin (manufactured by Sanwa Starch Co., Ltd.) was added to the obtained filtrate, dried and powdered with a spray dryer to obtain about 11 kg of lactic acid bacteria fermented γ-aminobutyric acid-rich material.

Figure 2007063236
Figure 2007063236

なお、本製造方法はγ−アミノ酪酸の調製の例示であり、本発明を限定するものではない。 In addition, this manufacturing method is an illustration of preparation of (gamma) -aminobutyric acid, and does not limit this invention.

(γ−アミノ酪酸濃度の測定)
各試料を0.2Nクエン酸ナトリウム緩衝液(pH2.2)で適宜希釈後、遠心分離又はろ過して固形物を除去し、測定試料とした。γ−アミノ酪酸の含量はアミノ酸含量測定の常法に従って高速液体クロマトグラフで以下の条件で分析した。
(Measurement of γ-aminobutyric acid concentration)
Each sample was appropriately diluted with 0.2N sodium citrate buffer (pH 2.2), and then centrifuged or filtered to remove solids, thereby preparing a measurement sample. The content of γ-aminobutyric acid was analyzed by a high performance liquid chromatograph under the following conditions in accordance with a conventional method for measuring amino acid content.

使用機器:(株)島津製作所製の高速液体クロマトグラフLC−9A
分析用カラム:強酸性陽イオン交換樹脂カラムShin−pack Isc−07Na型
移動層緩衝液:(株)島津製作所製のアミノ酸移動層キットNa型
移動層流量:0.3ml/分
反応層1:0.04%次亜塩素酸ナトリウム溶液(pH10のホウ酸−炭酸緩衝液500mlに対して次亜塩素酸0.2ml)
反応層2:(株)島津製作所製のアミノ酸分析キットOPA試薬
反応層流量:0.2ml/分
検出:蛍光検出 Ex348nm、Em450nm
Equipment used: High performance liquid chromatograph LC-9A manufactured by Shimadzu Corporation
Column for analysis: Strong acid cation exchange resin column Shin-pack Isc-07Na type moving bed buffer solution: amino acid moving bed kit manufactured by Shimadzu Corporation Na type moving bed flow rate: 0.3 ml / min reaction layer 1: 0 0.04% sodium hypochlorite solution (0.2 ml of hypochlorous acid per 500 ml of boric acid-carbonate buffer at pH 10)
Reaction layer 2: Amino acid analysis kit OPA reagent reaction layer manufactured by Shimadzu Corporation Flow rate: 0.2 ml / min Detection: fluorescence detection Ex 348 nm, Em 450 nm

上記測定法によれば、実施例1記載の発酵終了後発酵液のγ−アミノ酪酸含量は51g/Lであった。また、実施例1記載の粉末化乳酸菌発酵γ−アミノ酪酸高含有素材のγ−アミノ酪酸含量は21質量%であった。また、「ファーマギャバ100」(株式会社ファーマフーズ製)のγ−アミノ酪酸含量は100質量%であった。 According to the above measurement method, the content of γ-aminobutyric acid in the fermented liquid after completion of fermentation described in Example 1 was 51 g / L. Moreover, the γ-aminobutyric acid content of the powdered lactic acid bacteria fermented γ-aminobutyric acid-rich material described in Example 1 was 21% by mass. Moreover, the content of γ-aminobutyric acid of “Pharmaca 100” (manufactured by Pharma Foods) was 100% by mass.

ヒトでの睡眠の質を調べる為、ヒトボランティアを集め、睡眠試験を実施した。 In order to investigate the quality of sleep in humans, human volunteers were collected and a sleep test was conducted.

(被験者)
20歳から29歳までの健常男性5名を選抜し、これら全員に、就寝前に水を摂取する試験(対照群)と、γ‐アミノ酪酸を100mg含有する水溶液を摂取する試験(GABA群)とを、間に1週間以上の間を置いて合計2回行なってもらった。
(subject)
Five healthy men from the age of 20 to 29 were selected, and all of them were ingested with water before going to bed (control group) and with an aqueous solution containing 100 mg of γ-aminobutyric acid (GABA group). Were performed twice in total with a week or more in between.

(方法)
「ファーマギャバ100」(株式会社ファーマフーズ製)100mgを500mLの水道水に溶解したもの(GABA群)または対照用水道水500ml(対照群)を就寝60分前の午後10時に、被験者に飲用させた。被験者を快眠カプセル(ダイキン環境・空調技術研究所製)に入れ、午後10:30から付属の測定装置(ポリグラフ装置及び温度ロガー(サーミスタ))を常法にて装着し、測定準備を行った。午後11時就寝とし、脳波・心電・筋電・眼電・体表温(皮膚温)・深部体温(直腸温)の測定を開始した。翌日午前6時に起床させ、測定を終了した。脳波・心電図・筋電図・眼電図の結果を基にポリグラフ解析(詳細は、神山 潤著「睡眠の生理と臨床」(診断と治療社発行 2003)を参照)を行った。その一例を図1に示す。睡眠深度は、脳波や心電図・筋電図・眼電図をもとに判断されるが、深度の段階を脳波を目安に説明すると、睡眠深度1(最も浅い)ではα波(8〜13Hz)が50%以下、睡眠深度2では睡眠紡錘波が出現、睡眠深度3ではδ波(2Hz以下、75μV以上)が20%以上、睡眠深度4(最も深い)では、δ波が50%以上、となる。以下、入眠潜時とは、入眠、即ち就寝後の睡眠深度3へ至る移行時間を指す。また深睡眠時間とは、睡眠深度3または4の状態を保つ時間を指す。
(Method)
“Pharma Gabba 100” (manufactured by Pharma Foods Co., Ltd.) 100 mg dissolved in 500 mL of tap water (GABA group) or 500 mL of control tap water (control group) at 10 pm 60 minutes before bedtime It was. The test subject was put in a sleep capsule (Daikin Environment and Air Conditioning Technology Laboratory), and attached measurement devices (polygraph device and temperature logger (thermistor)) were attached in a usual manner from 10:30 pm, and preparation for measurement was performed. At 11:00 pm, measurement of EEG, electrocardiogram, myoelectric, electrooculogram, body surface temperature (skin temperature), and deep body temperature (rectal temperature) was started. The next day, it was woken up at 6 am and the measurement was completed. Based on the results of electroencephalogram, electrocardiogram, electromyogram and electrooculogram, polygraph analysis was performed (for details, see Jun Kamiyama "Sleep Physiology and Clinics" (published by Diagnosis and Treatment Company 2003)). An example is shown in FIG. The sleep depth is determined based on the electroencephalogram, electrocardiogram, electromyogram, and electrooculogram. If the depth stage is described using the electroencephalogram as a guide, the alpha wave (8 to 13 Hz) at the sleep depth 1 (the shallowest) Is 50% or less, sleep spindle wave appears at sleep depth 2, δ wave (2 Hz or less, 75 μV or more) is 20% or more at sleep depth 3, and δ wave is 50% or more at sleep depth 4 (deepest). Become. In the following, the sleep onset latency refers to the transition time to sleep onset, that is, the sleep depth 3 after going to bed. The deep sleep time refers to the time during which the sleep depth 3 or 4 is maintained.

(結果)
まずの深部体温(直腸温)の推移結果を図2に示す。GABA群では対照群よりも入眠時の深部体温の下がり方が急で大きく、就寝後50分で約0.3℃下がっていることが示された。
(result)
First, the transition results of the deep body temperature (rectal temperature) are shown in FIG. In the GABA group, the decrease in deep body temperature during sleep was sharper and greater than that in the control group, and it was shown that the temperature dropped by about 0.3 ° C. 50 minutes after going to bed.

次に各群の入眠潜時を図3に、就寝後60分以内の各群の深睡眠時間を図4に示す。 Next, the sleep latency of each group is shown in FIG. 3, and the deep sleep time of each group within 60 minutes after going to bed is shown in FIG.

図3と図4のように、GABA群では対照群よりも入眠にいたる時間が短く、深度3または4の深い睡眠の時間が長いことが示された。即ち、より寝つきが良く深い睡眠が得られることが示された。 As shown in FIG. 3 and FIG. 4, it was shown that the GABA group had a shorter time to fall asleep than the control group, and the deep sleep time at depth 3 or 4 was longer. That is, it was shown that sleep is better and deep sleep can be obtained.

以下、本発明の睡眠の質改善用組成物を含有する飲食品の処方例を挙げる。   Hereinafter, the formulation example of the food / beverage products containing the composition for sleep quality improvement of this invention is given.

(清涼飲料水)
実施例1で調製した乳酸菌発酵γ−アミノ酪酸高含有素材を含有する清涼飲料水を調製した。すなわち、組成が混合異性化糖1500g、レモン果汁1000g、乳酸菌発酵γ−アミノ酪酸高含有素材50g、香料
10g、炭酸カルシウム10gに水を加えて10Lとなるように原料を混合し、プレート殺菌機を用いて90℃、15秒間殺菌し、γ−アミノ酪酸を含有する睡眠の質改善用の清涼飲料水を製造した。即ち、飲料200mL中にγ−アミノ酪酸を約200mg含有する。
(Soft drink)
A soft drink containing the lactic acid bacteria fermented γ-aminobutyric acid-rich material prepared in Example 1 was prepared. That is, 1500 g of mixed isomerized sugar, 1000 g of lemon juice, 50 g of lactic acid bacteria fermented γ-aminobutyric acid high content material, 10 g of fragrance, and 10 g of calcium carbonate are mixed with the raw materials so that the total volume becomes 10 L. It was sterilized at 90 ° C. for 15 seconds to produce a soft drink containing γ-aminobutyric acid for improving sleep quality. That is, about 200 mg of γ-aminobutyric acid is contained in 200 mL of beverage.

(カプセル剤)
実施例1で得られた乳酸菌発酵γ−アミノ酪酸高含有素材90%、コーンスターチ10%を含むように各原料を配合して、ゼラチンカプセルに充填(カプセル1個当たり200mg)し、睡眠の質改善用のカプセル剤を製造した。
(Capsule)
Improve sleep quality by blending each raw material to contain 90% lactic acid bacteria fermented γ-aminobutyric acid-rich material and 10% corn starch obtained in Example 1 and filling into gelatin capsules (200mg per capsule) Capsules were prepared.

(錠剤)
実施例1で得られた乳酸菌発酵γ−アミノ酪酸高含有素材50%、還元麦芽糖18%、結晶セルロース28%、ショ糖エステル4%を含むように各原料を配合後打錠(1錠当たり300mg)して、睡眠の質改善用の錠剤を製造した。
(tablet)
Tableting (300 mg per tablet) after blending each raw material so as to contain 50% lactic acid bacteria fermented γ-aminobutyric acid-rich material obtained in Example 1, 18% reduced maltose, 28% crystalline cellulose, and 4% sucrose ester ) To produce tablets for improving sleep quality.

本発明の睡眠の質改善用組成物およびそれを含有する飲食品は、安全で安価なγ−アミノ酪酸を原料とし、就寝前の摂取により睡眠の質を改善し、ひいては疲労回復や美容、健康の増進、日中の作業効率の改善などに役立てることも可能となるため、機能性の食品や飲料として市販することができる。 The composition for improving sleep quality of the present invention and the food and drink containing the same are made from safe and inexpensive γ-aminobutyric acid, improve the quality of sleep by ingestion before going to bed, and eventually recover from fatigue, beauty and health It can also be used to improve the efficiency of work, improve work efficiency during the day, and can be marketed as functional foods and beverages.

実施例3に記載したヒトボランティア睡眠試験における睡眠ポリグラフ解析の一例を示した図である。FIG. 4 is a diagram showing an example of polysomnogram analysis in the human volunteer sleep test described in Example 3. 実施例3に記載したヒトボランティア睡眠試験の各群における深部体温(直腸温)の推移の平均を示したグラフである。It is the graph which showed the average of transition of the deep body temperature (rectal temperature) in each group of the human volunteer sleep test described in Example 3. 実施例3に記載したヒトボランティア睡眠試験の各群における入眠潜時(入眠への移行時間;分)の平均を示したグラフである。It is the graph which showed the average of sleep sleep latency (transition time to sleep sleep; minutes) in each group of the human volunteer sleep test described in Example 3. 実施例3に記載したヒトボランティア睡眠試験の各群における入眠後60分間中の深睡眠時間(睡眠深度3と4;分)の平均を示したグラフである。It is the graph which showed the average of the deep sleep time (sleep depth 3 and 4; min) in 60 minutes after falling asleep in each group of the human volunteer sleep test described in Example 3. FIG.

Claims (3)

γ―アミノ酪酸を有効成分として含有することを特徴とする、睡眠の質改善用組成物。 A composition for improving sleep quality, comprising γ-aminobutyric acid as an active ingredient. 就寝後の深部体温の低下を促すことを特徴とする請求項1記載の睡眠の質改善用組成物。 The composition for improving sleep quality according to claim 1, which promotes a decrease in deep body temperature after going to bed. 請求項1または2記載の睡眠の質改善用組成物を含有することを特徴とする飲食品。


A food or drink comprising the composition for improving sleep quality according to claim 1 or 2.


JP2005255104A 2005-09-02 2005-09-02 Composition for improving quality of sleep Pending JP2007063236A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005255104A JP2007063236A (en) 2005-09-02 2005-09-02 Composition for improving quality of sleep

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005255104A JP2007063236A (en) 2005-09-02 2005-09-02 Composition for improving quality of sleep

Publications (1)

Publication Number Publication Date
JP2007063236A true JP2007063236A (en) 2007-03-15

Family

ID=37925823

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005255104A Pending JP2007063236A (en) 2005-09-02 2005-09-02 Composition for improving quality of sleep

Country Status (1)

Country Link
JP (1) JP2007063236A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018020972A (en) * 2016-08-03 2018-02-08 三和酒類株式会社 Vigor and/or vitality improver that uses gaba as active ingredient
CN113875958A (en) * 2021-10-25 2022-01-04 宣城柏维力生物工程有限公司 Suction type functional sleep jelly and production process thereof
CN114081175A (en) * 2020-08-24 2022-02-25 内蒙古伊利实业集团股份有限公司 Composition and application thereof in preparation of sleep improvement product

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018020972A (en) * 2016-08-03 2018-02-08 三和酒類株式会社 Vigor and/or vitality improver that uses gaba as active ingredient
CN114081175A (en) * 2020-08-24 2022-02-25 内蒙古伊利实业集团股份有限公司 Composition and application thereof in preparation of sleep improvement product
CN113875958A (en) * 2021-10-25 2022-01-04 宣城柏维力生物工程有限公司 Suction type functional sleep jelly and production process thereof

Similar Documents

Publication Publication Date Title
JP4163631B2 (en) Fermentation composition of spicy varieties of chili pepper and its use
CN111989111B (en) Sleep-promoting composition, and pharmaceutical composition, food and drink composition using same
JP7041508B2 (en) Composition for improving circadian rhythm
JP2014047213A (en) Composition for releasing stress or for improving sleep disorder which contains fermented substance of mixture of oyster and seaweeds as active ingredient, and method of manufacturing the same
CN113499401A (en) Pharmaceutical composition for treating Alzheimer disease and preparation method and application thereof
JP2006062998A (en) Sleep improving agent
JP2007186495A (en) New unrefined vinegar having physical condition-improving effect
JP2024026804A (en) Improvement agent of fatigue, reduced motivation, or drowsiness
JP2008120754A (en) Antifatigue agent
JP2007063236A (en) Composition for improving quality of sleep
JP2010100663A (en) Enzyme inhibitor containing fermentation product of allium cepa l
JP2005097222A (en) Fermented product of allium cepa l.
JP2017190298A (en) Composition for producing hydrogen in body and supplement thereof
JP2006182654A (en) Body fat accumulation suppressing or reducing agent
JP2008074734A (en) Ameliorating agent for insulin resistance
JP2006256969A (en) Blood flow ameliorant
JP5222299B2 (en) Fat absorption inhibiting composition
KR20140017933A (en) Composition comprising fermented extract of trifoliate orange for improving diabetes
WO2019071193A1 (en) Inactivated bacillus coagulans and uses thereof for reducing stress
JP5585075B2 (en) Growth hormone secretagogue
JP2006335721A (en) Stiffened shoulders improving composition
JP2006265142A (en) Body fat accumulation inhibiting or decreasing agent
JP2011153125A (en) Autonomic control agent containing pseudo-leaf of asparagus as active ingredient
JP2005239686A (en) Body fat combustion promotion composition and food or medicine containing the same
JP2002029984A (en) Oral composition